302 related articles for article (PubMed ID: 21426030)
1. Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
Moya IA; Su Z; Honek JF
Future Med Chem; 2009 Jul; 1(4):619-43. PubMed ID: 21426030
[TBL] [Abstract][Full Text] [Related]
2. Drug targets and mechanisms of resistance in the anaerobic protozoa.
Upcroft P; Upcroft JA
Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
[TBL] [Abstract][Full Text] [Related]
3. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.
Cedillo-Rivera R; Chávez B; González-Robles A; Tapia A; Yépez-Mulia L
J Eukaryot Microbiol; 2002; 49(3):201-8. PubMed ID: 12120985
[TBL] [Abstract][Full Text] [Related]
4. [In vitro effect of metronidazole ester on Trichomonas vaginalis and Entamoeba histolytica].
He Y; Tao X; Guan L; Lian W
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(1):32-4. PubMed ID: 7788891
[TBL] [Abstract][Full Text] [Related]
5. Sexually transmitted protozoal infections. Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia.
Moldwin RM
Urol Clin North Am; 1992 Feb; 19(1):93-101. PubMed ID: 1736479
[TBL] [Abstract][Full Text] [Related]
6. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea.
Upcroft JA; Dunn LA; Wal T; Tabrizi S; Delgadillo-Correa MG; Johnson PJ; Garland S; Siba P; Upcroft P
Sex Health; 2009 Dec; 6(4):334-8. PubMed ID: 19917203
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
[TBL] [Abstract][Full Text] [Related]
8. Prevalent, treatable and significant: barriers to the control of Trichomonas vaginalis in women.
Hillier SL
Sex Transm Infect; 2013 Sep; 89(6):415. PubMed ID: 23956294
[No Abstract] [Full Text] [Related]
9. Metronidazole metabolism in cultures of Entamoeba histolytica and Trichomonas vaginalis.
Beaulieu BB; McLafferty MA; Koch RL; Goldman P
Antimicrob Agents Chemother; 1981 Sep; 20(3):410-4. PubMed ID: 6272633
[TBL] [Abstract][Full Text] [Related]
10. The clinical spectrum of Trichomonas vaginalis infection and challenges to management.
Muzny CA; Schwebke JR
Sex Transm Infect; 2013 Sep; 89(6):423-5. PubMed ID: 23543252
[TBL] [Abstract][Full Text] [Related]
11. 1,4-Bis-[1-methyl-5-nitroimidazolyl-(2-methyleneimino)]-piperazine, a new drug with marked activity against Entamoeba histolytica. Short communication.
Raether W; Seidenath H; Winkelmann E
Arzneimittelforschung; 1977; 27(5):968-9. PubMed ID: 195590
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro antiprotozoal activity of benzimidazole-pentamidine hybrids.
Torres-Gómez H; Hernández-Núñez E; León-Rivera I; Guerrero-Alvarez J; Cedillo-Rivera R; Moo-Puc R; Argotte-Ramos R; Rodríguez-Gutiérrez Mdel C; Chan-Bacab MJ; Navarrete-Vázquez G
Bioorg Med Chem Lett; 2008 Jun; 18(11):3147-51. PubMed ID: 18486471
[TBL] [Abstract][Full Text] [Related]
13. [Trichomonacidal and amebicidal properties of flunidazole, (hydroxy-2' ethyl)-1 (p. fluorophenyl) 2-nitro 5-imidazole)].
Cavier R; Cenac J
Therapie; 1972; 27(4):733-42. PubMed ID: 4538856
[No Abstract] [Full Text] [Related]
14. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
Leitsch D
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
[TBL] [Abstract][Full Text] [Related]
15. Antiprotozoal activity of proton-pump inhibitors.
Pérez-Villanueva J; Romo-Mancillas A; Hernández-Campos A; Yépez-Mulia L; Hernández-Luis F; Castillo R
Bioorg Med Chem Lett; 2011 Dec; 21(24):7351-4. PubMed ID: 22047694
[TBL] [Abstract][Full Text] [Related]
16. Highly Potent 1
Kumar S; Bains T; Won Kim AS; Tam C; Kim J; Cheng LW; Land KM; Debnath A; Kumar V
Front Cell Infect Microbiol; 2018; 8():380. PubMed ID: 30425970
[TBL] [Abstract][Full Text] [Related]
17. Entamoeba histolytica and Trichomonas vaginalis: trophozoite growth inhibition by metronidazole electro-transferred water.
Heredia-Rojas JA; Torres-Flores AC; Rodríguez-De la Fuente AO; Mata-Cárdenas BD; Rodríguez-Flores LE; Barrón-González MP; Torres-Pantoja AC; Alcocer-González JM
Exp Parasitol; 2011 Jan; 127(1):80-3. PubMed ID: 20603119
[TBL] [Abstract][Full Text] [Related]
18. Should expedited partner treatment for women with Trichomonas vaginalis be recommended?
Kissinger P
Sex Transm Dis; 2010 Jun; 37(6):397-8. PubMed ID: 20453719
[No Abstract] [Full Text] [Related]
19. [A new antitrichomonal agent, tinidazole].
Di Carlo R
G Batteriol Virol Immunol; 1974; 67(7-12):257-72. PubMed ID: 4377559
[No Abstract] [Full Text] [Related]
20. Molecular modeling and docking analysis of Entamoeba histolytica glyceraldehyde-3 phosphate dehydrogenase, a potential target enzyme for anti-protozoal drug development.
Singh S; Malik BK; Sharma DK
Chem Biol Drug Des; 2008 Jun; 71(6):554-62. PubMed ID: 18489439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
